Addario Lung Cancer Medical Institute
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Addario Lung Cancer Medical Institute sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Addario Lung Cancer Medical Institute: 8 sponsored US clinical trials, 1 recruiting.
Addario Lung Cancer Medical Institute sponsors 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 2 completed. The most-studied condition in this pipeline is Kras P.G12C, with 1 trials.
Upper-quartile sponsor footprint
Addario Lung Cancer Medical Institute sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
NCT06486428
Studying Pathways of Resistance in KRAS-driven Cancers
NCT05272423
Epidemiology of Young Lung Cancer - Survey
NCT04640259
A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)
NCT07075627
Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy
NCT04676386
Study of Plasma NGS for Assessment, Characterization, Evaluation of Patients With ALK Resistance
NCT03833934
Role of Circulating Tumor DNA (ctDNA) From LIquid Biopsy in Early Stage NSCLC Resected Lung Tumor Investigation
NCT03553550
ALCMI-006: A Prospective Biospecimen Collection Study From Patients With ROS1-Fusion Positive Tumors
NCT03497624
Therapeutic Areas
What is open in the Addario Lung Cancer Medical Institute pipeline
1 recruiting of 8 indexed (13% open); 2 completed (25%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Kras P.G12C (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Addario Lung Cancer Medical Institute: open-pipeline peers nationwide
Peers matched on 8 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Addario Lung Cancer Medical Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 13% open enrollment (± trial volume)
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
- Avidity Biosciences · 13% recruiting · 8 trials
Related
What to do with this Addario Lung Cancer Medical Institute page
8 registered trials is a research-attention snapshot, not an endorsement of Addario Lung Cancer Medical Institute or any single study.
- 1 of Addario Lung Cancer Medical Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Kras P.G12C is the condition Addario Lung Cancer Medical Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Kras P.G12C trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Addario Lung Cancer Medical Institute pipeline card: 8 registered trials from official public datasets.Report a data error.